TY - JOUR
T1 - Hypoxia, HIF, and associated signaling networks in chronic kidney disease
AU - Liu, Jing
AU - Wei, Qingqing
AU - Guo, Chunyuan
AU - Dong, Guie
AU - Liu, Yu
AU - Tang, Chengyuan
AU - Dong, Zheng
N1 - Publisher Copyright:
© 2017 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2017/5
Y1 - 2017/5
N2 - The pathogenesis of chronic kidney disease (CKD) is complex and apparently multifactorial. Hypoxia or decrease in oxygen supply in kidney tissues has been implicated in CKD. Hypoxia inducible factors (HIF) are a small family of transcription factors that are mainly responsive to hypoxia and mediate hypoxic response. HIF plays a critical role in renal fibrosis during CKD through the modulation of gene transcription, crosstalk with multiple signaling pathways, epithelial-mesenchymal transition, and epigenetic regulation. Moreover, HIF also contributes to the development of various pathological conditions associated with CKD, such as anemia, inflammation, aberrant angiogenesis, and vascular calcification. Treatments targeting HIF and related signaling pathways for CKD therapy are being developed with promising clinical benefits, especially for anemia. This review presents an updated analysis of hypoxia response, HIF, and their associated signaling network involved in the pathogenesis of CKD.
AB - The pathogenesis of chronic kidney disease (CKD) is complex and apparently multifactorial. Hypoxia or decrease in oxygen supply in kidney tissues has been implicated in CKD. Hypoxia inducible factors (HIF) are a small family of transcription factors that are mainly responsive to hypoxia and mediate hypoxic response. HIF plays a critical role in renal fibrosis during CKD through the modulation of gene transcription, crosstalk with multiple signaling pathways, epithelial-mesenchymal transition, and epigenetic regulation. Moreover, HIF also contributes to the development of various pathological conditions associated with CKD, such as anemia, inflammation, aberrant angiogenesis, and vascular calcification. Treatments targeting HIF and related signaling pathways for CKD therapy are being developed with promising clinical benefits, especially for anemia. This review presents an updated analysis of hypoxia response, HIF, and their associated signaling network involved in the pathogenesis of CKD.
KW - CKD
KW - Fibrosis
KW - HIF
KW - Hypoxia
UR - http://www.scopus.com/inward/record.url?scp=85018423108&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85018423108&partnerID=8YFLogxK
U2 - 10.3390/ijms18050950
DO - 10.3390/ijms18050950
M3 - Review article
C2 - 28468297
AN - SCOPUS:85018423108
SN - 1661-6596
VL - 18
JO - International journal of molecular sciences
JF - International journal of molecular sciences
IS - 5
M1 - 950
ER -